MRI‐based prostate volume‐adjusted prostate‐specific antigen in the diagnosis of prostate cancer
Authors:
- Yahui PengYahui Peng
- Dinggang ShenDSDinggang Shen
- Shu LiaoSLShu Liao
- Baris TurkbeyBTBaris Turkbey
- Soroush Rais‐BahramiSRSoroush Rais‐Bahrami
- Bradford WoodBWBradford Wood
- Ibrahim KarademirIKIbrahim Karademir
- Tatjana AnticTATatjana Antic
- Yulei JiangYJYulei Jiang
- Peter A. PintoPPPeter A. Pinto
- Peter L. ChoykePCPeter L. Choyke
Open Access
- 6 May 2015
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 42 (6) , 1733-1739
Abstract
Purpose To determine whether prostate‐specific antigen (PSA) levels adjusted by prostate and zonal volumes estimated from magnetic resonance imaging (MRI) improve the diagnosis of prostate cancer (PCa) and differentiation between patients who harbor high‐Gleason‐sum PCa and those without PCa. Materials and Methods This retrospective study was Health Insurance Portability and Accountability Act (HIPAA)‐compliant and approved by the Institutional Review Board of participating medical institutions. T2‐weighted MR images were acquired for 61 PCa patients and 100 patients with elevated PSA but without PCa. Computer methods were used to segment prostate and zonal structures and to estimate the total prostate and central‐gland (CG) volumes, which were then used to calculate CG volume fraction, PSA density, and PSA density adjusted by CG volume. These quantities were used to differentiate patients with and without PCa. Area under the receiver operating characteristic curve (AUC) was used as the figure of merit. Results The total prostate and CG volumes, CG volume fraction, and PSA density adjusted by the total prostate and CG volumes were statistically significantly different between patients with PCa and patients without PCa (P ≤ 0.007). AUC values for the total prostate and CG volumes, and PSA density adjusted by CG volume, were 0.68 ± 0.04, 0.68 ± 0.04, and 0.66 ± 0.04, respectively, and were significantly better than that of PSA (P < 0.02), for differentiation of PCa patients from patients without PCa. Conclusion The total prostate and CG volumes estimated from T2‐weighted MR images and PSA density adjusted by these volumes can improve the effectiveness of PSA for the diagnosis of PCa and differentiation of high‐Gleason‐sum PCa patients from patients without PCa. J. MAGN. RESON. IMAGING 2015;42:1733–1739.Keywords
Funding Information
- US Army Medical Research and Materiel Command Prostate Cancer Research Program (Idea Development Award PC093485)
- Beijing Jiaotong University Talent Fund (2013RC028)
This publication has 41 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Automated Computer-derived Prostate Volumes from MR Imaging Data: Comparison with Radiologist-derived MR Imaging and Pathologic Specimen VolumesRadiology, 2012
- Predicting the probability of significant prostate cancer in Japanese men with serum prostate-specific antigen less than 10 ng/mL: Development of a novel pre-biopsy nomogramInternational Journal of Urology, 2010
- Transrectal Ultrasound versus Magnetic Resonance Imaging in the Estimation of Prostate Volume as Compared with Radical Prostatectomy SpecimensUrologia Internationalis, 2007
- Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for prostate cancer patients with intermediate PSA levelsProstate Cancer and Prostatic Diseases, 2007
- Prostate-specific antigen adjusted for the transition zone volume as a second screening test: A prospective study of 248 casesInternational Journal of Urology, 2006
- Prostate cancers in the transition zone: Part 2; clinical aspectsBJU International, 2004
- Diagnostic Significance of PSA Density Adjusted by Transition Zone Volume in Males with PSA Levels between 2 and 4ng/mlEuropean Urology, 2004
- PROSTATE SPECIFIC ANTIGEN DENSITY OF THE TRANSITION ZONE FOR EARLY DETECTION OF PROSTATE CANCERJournal of Urology, 1998
- MR Depiction of Zonal Anatomy of the Prostate at 1.5 TJournal of Computer Assisted Tomography, 1986